Introduction
The d-transposition of great arteries (d-TGA) is a common, but serious congenital heart malformation, with an incidence of about 1 per 5000 live births. Until the late 1950's, this lesion was uniformly fatal, with most infants dying before the age of 1 year. The development of the Senning and Mustard atrial-level repairs in the late 1950's and early 1960's led to good immediate outcomes and long-term survival. With improved surgical techniques for congenital heart disease (CHD), the survival of patients with CHD has increased. 1 Pregnancy has generally been well tolerated in patients, with atrial-level repairs for d-TGA, who are asymptomatic at baseline.
Total anomalous pulmonary venous return (TAPVR) is a rare form of cyanotic CHD, which without surgical treatment has a high mortality in the first year of life. Reports of familial recurrence of TAPVR have involved siblings, first cousins and twins. The implication of non-syndromic familial reoccurrence of these lesions is important for genetic counseling to families with this anomaly and individuals reaching adulthood after repair.
Case Case 1 is a 30-year-old woman, gravida 2, para 1, with diagnosis of d-TGA. She was born at full term by normal vaginal delivery and was found to have a heart murmur and polydactyly at birth. She was diagnosed with d-TGA on her 2-week well child visit due to heart murmur and cyanosis. She underwent Rashkind balloon atrial septostomy and was discharged home. At 6 months of age, she was cyanotic with polycythemia and subsequently underwent Mustard atrial baffle procedure. She remains asymptomatic with good systemic right ventricular function. At 27 years of age, she gave birth to a healthy boy. With her second pregnancy, she had a fetal echocardiogram at 25-weeks gestation, with d-TGA diagnosed in the fetus. She underwent induction at 39 weeks of gestation and had a normal vaginal delivery. The infant underwent an arterial switch operation with an uneventful postoperative course. A pedigree of the family, with three generations on the maternal side, showed no additional cases of d-TGA (Figure 1 ) or other CHD. There is no consanguinity of the parents. Genetic evaluation for 22q deletion by fluorescent in situ hybridization and comparative genomic hybridization studies on the newborn were normal.
Case 2 is a 32-year-old woman, gravida 2, para 1, with no CHD. Her first child, a female, was born at 41-weeks gestational age. During the newborn period, the infant was hypoxic, cyanotic and had pulmonary hypertension. The infant was subsequently diagnosed with infradiaphragmatic TAPVR that was successfully repaired. During her second pregnancy, the mother underwent fetal echocardiography at 29-weeks gestation and the fetus was diagnosed with supradiaphragmatic TAPVR. There is no consanguinity of the parents or clinically identifiable syndrome. The second affected infant has not been delivered at the time of this report.
Discussion
Familial recurrence risk of CHD has been reported as 4%.
2,3 New genetic techniques including comparative genomic hybridization, rapid and less expensive candidate gene sequencing and whole genome sequencing may allow the identification of causative or predisposing genes for CHD in families. The d-TGA most often occurs sporadically and is rarely associated with genetic syndromes. There have been reports of isolated non-syndromic TGA reoccurrance in siblings. Becker et al. 4 and Burn et al. 2 reported a sibling recurrence risk of 0.27 to 1.4% and 1.8%, respectively. These rare reoccurrences in families suggest monogenic or oligogenic inheritance of this disorder in some cases. 5 Reports have implicated mutations in the laterality genes in familial reoccurrence of d-TGA. 6 Familial precurrence of CHD in parents of patients with d-TGA has been reported, but these were parents who had discordant CHD, not d-TGA. 4 There is one report of a father and son with isolated d-TGA diagnosed on fetal echocardiography. 7 So far, there have been no reports of d-TGA in mother and offspring.
There have been several reports in the literature of sibling recurrence of TAPVR. 8, 9 The affected siblings may have either the same or different subtypes of TAPVR. A large family study of TAPVR-affected family members, who were related via unaffected carriers allowed mapping of the TAPVR gene to chromosome 4, with identification of PDGFRA gene dysregulation as a possible cause of a spectrum of pulmonary vein anomalies, including TAPVR. 10 Of the affected siblings in the literature, reported cases of male-male siblings with TAPVR predominate. In this report, we describe TAPVR in siblings, in which at least one of the siblings is a female.
Conclusion
Prenatal diagnosis and improved medical management and surgical repair have led to improved survival in patients with CHD. More patients with CHD are reaching childbearing age and we are beginning to observe new transmission patterns for more severe, isolated CHD. We present the first reported case of a mother and offspring with isolated d-TGA, suggesting Mendelian inheritance for this form of CHD. We also present two siblings with isolated nonsyndromic TAPVR, suggesting the possibility of a new germline mutation in one of the parents. Further studies on the offspring of adults with CHD and cases of familial reoccurrence will help identify genetic factors contributing to the inheritance of isolated CHD. 
